Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiya Horimoto

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
Surgical Case Reports|August 27, 2021
Drug-induced aortitis of the subclavian artery caused by pegfilgrastim: a case reportHikari Jimbo, Yoshiya Horimoto, Misato Okazaki, et al.
Case Reports in Oncology|March 29, 2021
Cardiotoxicity after Additional Administration of Pertuzumab following Long-Term Trastuzumab: Report of 2 CasesMayuko Ito, Yoshiya Horimoto, Ritsuko Sasaki, et al.
The Journal of Surgical Research|December 19, 2009
Significance of HER2 protein examination in ductal carcinoma in situYoshiya Horimoto, Emi Tokuda, Atsushi Arakawa, et al.
BMC Cancer|March 6, 2022
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patientsYoshiya Horimoto, Yumiko Ishizuka, Yuko Ueki, et al.
Case Reports in Oncology|March 29, 2021
Granular Cell Tumor of the Breast Coexisting with Ductal Carcinoma in situ: Case ReportYuko Ueki, Yoshiya Horimoto, Akihiko Shiraishi, et al.
Breast Cancer (Tokyo, Japan)|November 6, 2025
Current practices and challenges in margin evaluation for breast-conserving surgery specimens: a nationwide survey in Japan with international benchmarkingYoshiya Horimoto, Hiroshi Kaise, Takashi Ishikawa, et al.
Breast Cancer Research and Treatment|September 26, 2022
Absolute lymphocyte count decreases with disease progression and is a potential prognostic marker for metastatic breast cancerHikari Jimbo, Yoshiya Horimoto, Yumiko Ishizuka, et al.
Annals of Surgical Oncology|March 3, 2016
Activated Caspase 3 Expression in Remnant Disease After Neoadjuvant Chemotherapy May Predict Outcomes of Breast Cancer PatientsTakanori Himuro, Yoshiya Horimoto, Atsushi Arakawa, et al.
Plos One|October 22, 2016
Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant MetastasesYoshiya Horimoto, Atsushi Arakawa, Noriko Sasahara, et al.
Case Reports in Oncology|October 30, 2023
Encapsulated Papillary Carcinoma in an Elderly Male Whose Diagnosis Was Difficult before Surgery: A Case ReportMaho Sugino, Yoshiya Horimoto, Fumi Murakami, et al.
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
Surgical Case Reports|August 27, 2021
Drug-induced aortitis of the subclavian artery caused by pegfilgrastim: a case reportHikari Jimbo, Yoshiya Horimoto, Misato Okazaki, et al.
Case Reports in Oncology|March 29, 2021
Cardiotoxicity after Additional Administration of Pertuzumab following Long-Term Trastuzumab: Report of 2 CasesMayuko Ito, Yoshiya Horimoto, Ritsuko Sasaki, et al.
The Journal of Surgical Research|December 19, 2009
Significance of HER2 protein examination in ductal carcinoma in situYoshiya Horimoto, Emi Tokuda, Atsushi Arakawa, et al.
BMC Cancer|March 6, 2022
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patientsYoshiya Horimoto, Yumiko Ishizuka, Yuko Ueki, et al.
Case Reports in Oncology|March 29, 2021
Granular Cell Tumor of the Breast Coexisting with Ductal Carcinoma in situ: Case ReportYuko Ueki, Yoshiya Horimoto, Akihiko Shiraishi, et al.
Breast Cancer (Tokyo, Japan)|November 6, 2025
Current practices and challenges in margin evaluation for breast-conserving surgery specimens: a nationwide survey in Japan with international benchmarkingYoshiya Horimoto, Hiroshi Kaise, Takashi Ishikawa, et al.
Breast Cancer Research and Treatment|September 26, 2022
Absolute lymphocyte count decreases with disease progression and is a potential prognostic marker for metastatic breast cancerHikari Jimbo, Yoshiya Horimoto, Yumiko Ishizuka, et al.
Annals of Surgical Oncology|March 3, 2016
Activated Caspase 3 Expression in Remnant Disease After Neoadjuvant Chemotherapy May Predict Outcomes of Breast Cancer PatientsTakanori Himuro, Yoshiya Horimoto, Atsushi Arakawa, et al.
Plos One|October 22, 2016
Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant MetastasesYoshiya Horimoto, Atsushi Arakawa, Noriko Sasahara, et al.
Case Reports in Oncology|October 30, 2023
Encapsulated Papillary Carcinoma in an Elderly Male Whose Diagnosis Was Difficult before Surgery: A Case ReportMaho Sugino, Yoshiya Horimoto, Fumi Murakami, et al.
Pageof 13